COMMON VARIABLE IMMUNODEFICIENCY (CVID)
DEFINITION:
A heterogeneous group of B-cell disorders characterized by
hypogammaglobulinemia resulting in the late onset of recurrent sino-pulmonary
and gastrointestinal infections.
EPIDEMIOLOGY:
- incidence: ?
- age of onset:
- 2nd and 3rd decades; rarely before 6 years of age
- risk factors:
- familial - autosomal recessive and dominant forms
- M = F
PATHOGENESIS:
- autosomal recessive and dominant forms
- increased incidence of hypogammaglobulinemia, Selective
IgA Deficiency, autoimmune disease, and neoplasms among first
degree relatives
2. Acquired
- may also be acquired forms
2. Defect
- hypothesized that a variety of factors (hereditary and
acquired) result in the failure of B cells to undergo terminal
plasma cell differentiation and/or to secrete immunoglobulins ->
humoral-me-iated immunodeficiency -> persistent infections by
encapsulated bacteria (H. flu, pneumococcus, staphylococcus),
mycoplasma, or ureaplasma
- the differentiation of B-cells into antibody-secreting cells
may be blocked at any number of sites
- may represent a heterogeneous group of disorders where the B
cells fail to receive or respond to normal maturational signals
as B-cells from patients with CVID have the capacity to
differen-tiate into plasma cells when exposed to an appropriate
set of stimuli in vitro
- apart from a later onset, the clinical manifestations of
CVID may be indistinguishable from those of Bruton Disease
CLINICAL FEATURES:
1. Immunodeficiency Manifestations
1. Respiratory
1. Sinopulmonary Infections (90%)
- may be chronic and recurrent
- paranasal sinusitis, bronchitis, chronic cough
- chronic otitis media (30%)
2. Serious Pulmonary Involvement
- 30-40% progress to develop serious pulmonary involvement
- pneumonia
- interstitial fibrosis
- panlobular emphysema
- chronic lung disease
- chronic progressive bronchiectasis
2. Gastrointestinal
1. Chronic Diarrhea (60%) +/-
- malabsorption (vitamin B12) +/- steatorrhea
- protein-loosing enteropathy
- giardiasis (35-65%)
- clostridium difficle (24%)
2. Others
- bacterial overgrowth, disaccharidase deficiency, jejunal
villous atrophy, lactose intolerance, Nodular
- Lymphoid Hyperplasia
2. Complications
1. Autoimmune Disorders
- hemolytic anemia, pernicious anemia (5%), autoimmune
neutro-penia
- Rheumatoid Arthritis, SLE, ITP, Dermatomyositis, Scleroder-ma,
Chronic Active Hepatitis
2. Neoplasms
- present in the 5th to 6th decades
- reticuloendothelial tumors (lymphomas)
- stomach cancer
3. Infectious
- noncaseating granulomas of the lungs, spleen, liver, skin
- vaccine-associated poliomyelitis
- infectious mononucleosis
- echovirus meningoencephalitis and dermatomyositis
4. Others
- nondeforming polyarthritis and/or polyarthralgias
- Amyloidosis
- Hemolytic Uremic Syndrome
- cutaneous anergy (in up to 50% of cases)
INVESTIGATIONS:
1. Serum
1. Humoral-Mediated
- variable number of circulating B-cells from decreased to
increased (there are only a few circulating immature B-cells
in Bruton Disease)
- proliferating B-cells may cause splenomegaly, hepatomegaly,
and hypertrophy of lymph nodes & intestinal lymphoid tissue -
absence of plasma cells in some lymphoid tissues (lymph nodes,
bone marrow, tonsils, spleen)
- reduced levels of IgG, IgA, and IgM (IgM tends to be less
affected)
- diverse expression of surface immunoglobulins on B-cells
- increased incidence of autoantibodies (rheumatoid factor,
anti-RBC antibodies, antibodies to T- or B-cells)
- markedly reduced antibody response on challenge with a
variety of antigens
2. Cell-Mediated
- normal number and function of T cells, i.e., initially
there is normal cell-mediated immunity
- normal CD4+ T Helper Cell number and function
- normal or increased CD8+ T Suppressor Cell number
- as patients age, significant T-cell abnormalities may
develop
3. CBC
- pancytopenia - anemia (40%), leukopenia, lymphopenia
- anemia may be due to folate or Vitamin B12 malabsorption
MANAGEMENT:
1. Supportive
- antibiotics for specific infections
- flagyl for giardiasis
- corticosteroids for noncaseating granulomas
- follow for the development of autoimmune disorders or other
complications and treat any that develop
2. Immunosuppression
1. Intravenous Immunoglobulin (IV IgG)
- 0.1-0.6 g/kg/month
- indications:
- severe sinopulmonary infections
- echovirus-induced meningoencephalitis and
dermatomyo-sitis
- polyarthritis and/or polyarthralgia
2. Cimetidine
- may reverse T Suppressor activity and subsequently
increase serum IgG levels
3. Prognosis
- increased mortality especially from late-onset malignancies
|